Harrow Current Deferred Revenue vs Non Current Assets Total Analysis

HROW Stock

USD 10.53 0.53 5.30%

Harrow Health financial indicator trend analysis is much more than just examining Harrow Health latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Harrow Health is a good investment. Please check the relationship between Harrow Health Current Deferred Revenue and its Non Current Assets Total accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.

Current Deferred Revenue vs Non Current Assets Total

Current Deferred Revenue vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Harrow Health Current Deferred Revenue account and Non Current Assets Total. At this time, the significance of the direction appears to have very week relationship.

The correlation between Harrow Health's Current Deferred Revenue and Non Current Assets Total is 0.21. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Harrow Health, assuming nothing else is changed. The correlation between historical values of Harrow Health's Current Deferred Revenue and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Harrow Health are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Current Deferred Revenue i.e., Harrow Health's Current Deferred Revenue and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.21

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Current Deferred Revenue

Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most indicators from Harrow Health's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Harrow Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.At this time, Harrow Health's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to climb to about 736 K in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.73 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	54.3M	63.2M	90.6M	95.1M
Total Revenue	72.5M	88.6M	130.2M	136.7M

Gross Profit Total Revenue

Harrow Health fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Other Stockholder Equity	Total Liab	Total Current Assets	Common Stock	Short Long Term Debt Total	Other Current Assets	Accounts Payable	Non Current Liabilities Total	Property Plant And Equipment Net	Non Current Assets Total	Property Plant And Equipment Gross	Other Liab	Long Term Debt	Net Tangible Assets	Current Deferred Revenue	Retained Earnings Total Equity
Total Assets		0.92	0.98	0.94	0.95	-0.82	0.86	0.9	0.8	0.77	0.93	1.0	0.97	0.59	0.99	0.66	0.95	0.99	0.74	0.98	0.86	0.2	0.99	-0.13	0.27	-0.69
Other Current Liab	0.92		0.95	0.9	0.98	-0.67	0.63	0.66	0.64	0.61	0.82	0.91	0.8	0.39	0.9	0.35	0.79	0.89	0.57	0.98	0.66	0.2	0.89	-0.15	0.14	-0.49
Total Current Liabilities	0.98	0.95		0.95	0.96	-0.82	0.77	0.83	0.8	0.77	0.93	0.97	0.92	0.58	0.96	0.58	0.94	0.95	0.75	0.98	0.83	0.29	0.95	-0.08	0.34	-0.69
Total Stockholder Equity	0.94	0.9	0.95		0.89	-0.75	0.73	0.83	0.77	0.78	0.9	0.91	0.9	0.56	0.89	0.53	0.89	0.89	0.73	0.93	0.78	0.12	0.88	0.19	0.25	-0.61
Net Debt	0.95	0.98	0.96	0.89		-0.76	0.67	0.73	0.75	0.72	0.87	0.94	0.85	0.52	0.94	0.41	0.84	0.93	0.7	0.98	0.78	0.23	0.92	-0.17	0.22	-0.62
Retained Earnings	-0.82	-0.67	-0.82	-0.75	-0.76		-0.74	-0.82	-0.92	-0.94	-0.96	-0.82	-0.84	-0.83	-0.82	-0.62	-0.85	-0.81	-0.9	-0.76	-0.92	-0.52	-0.8	0.07	-0.3	0.97
Cash	0.86	0.63	0.77	0.73	0.67	-0.74		0.95	0.69	0.66	0.78	0.88	0.94	0.55	0.89	0.9	0.9	0.9	0.62	0.75	0.84	0.12	0.9	-0.26	0.26	-0.68
Cash And Short Term Investments	0.9	0.66	0.83	0.83	0.73	-0.82	0.95		0.83	0.82	0.87	0.9	0.98	0.7	0.9	0.85	0.93	0.91	0.78	0.78	0.93	0.13	0.9	-0.02	0.33	-0.77
Common Stock Total Equity	0.8	0.64	0.8	0.77	0.75	-0.92	0.69	0.83		0.94	0.92	0.79	0.83	0.9	0.79	0.58	0.82	0.78	0.94	0.73	0.93	0.36	0.77	0.09	0.4	-0.89
Common Stock Shares Outstanding	0.77	0.61	0.77	0.78	0.72	-0.94	0.66	0.82	0.94		0.93	0.76	0.82	0.85	0.75	0.54	0.8	0.75	0.95	0.7	0.92	0.33	0.73	0.2	0.27	-0.93
Other Stockholder Equity	0.93	0.82	0.93	0.9	0.87	-0.96	0.78	0.87	0.92	0.93		0.91	0.92	0.76	0.9	0.62	0.92	0.9	0.89	0.88	0.92	0.39	0.89	0.02	0.3	-0.88
Total Liab	1.0	0.91	0.97	0.91	0.94	-0.82	0.88	0.9	0.79	0.76	0.91		0.97	0.58	1.0	0.68	0.95	1.0	0.72	0.97	0.87	0.21	1.0	-0.21	0.28	-0.71
Total Current Assets	0.97	0.8	0.92	0.9	0.85	-0.84	0.94	0.98	0.83	0.82	0.92	0.97		0.66	0.97	0.79	0.97	0.97	0.78	0.89	0.92	0.17	0.97	-0.08	0.32	-0.75
Common Stock	0.59	0.39	0.58	0.56	0.52	-0.83	0.55	0.7	0.9	0.85	0.76	0.58	0.66		0.58	0.51	0.65	0.57	0.86	0.49	0.82	0.34	0.56	0.15	0.4	-0.83
Short Long Term Debt Total	0.99	0.9	0.96	0.89	0.94	-0.82	0.89	0.9	0.79	0.75	0.9	1.0	0.97	0.58		0.68	0.95	1.0	0.72	0.96	0.87	0.19	1.0	-0.23	0.26	-0.7
Other Current Assets	0.66	0.35	0.58	0.53	0.41	-0.62	0.9	0.85	0.58	0.54	0.62	0.68	0.79	0.51	0.68		0.81	0.7	0.54	0.51	0.71	0.13	0.7	-0.19	0.45	-0.62
Accounts Payable	0.95	0.79	0.94	0.89	0.84	-0.85	0.9	0.93	0.82	0.8	0.92	0.95	0.97	0.65	0.95	0.81		0.95	0.78	0.89	0.89	0.26	0.95	-0.11	0.43	-0.77
Non Current Liabilities Total	0.99	0.89	0.95	0.89	0.93	-0.81	0.9	0.91	0.78	0.75	0.9	1.0	0.97	0.57	1.0	0.7	0.95		0.71	0.96	0.87	0.19	1.0	-0.24	0.26	-0.7
Property Plant And Equipment Net	0.74	0.57	0.75	0.73	0.7	-0.9	0.62	0.78	0.94	0.95	0.89	0.72	0.78	0.86	0.72	0.54	0.78	0.71		0.66	0.93	0.41	0.69	0.18	0.41	-0.91
Non Current Assets Total	0.98	0.98	0.98	0.93	0.98	-0.76	0.75	0.78	0.73	0.7	0.88	0.97	0.89	0.49	0.96	0.51	0.89	0.96	0.66		0.77	0.21	0.96	-0.16	0.21	-0.61
Property Plant And Equipment Gross	0.86	0.66	0.83	0.78	0.78	-0.92	0.84	0.93	0.93	0.92	0.92	0.87	0.92	0.82	0.87	0.71	0.89	0.87	0.93	0.77		0.32	0.86	-0.05	0.35	-0.91
Other Liab	0.2	0.2	0.29	0.12	0.23	-0.52	0.12	0.13	0.36	0.33	0.39	0.21	0.17	0.34	0.19	0.13	0.26	0.19	0.41	0.21	0.32		0.18	-0.19	0.29	-0.52
Long Term Debt	0.99	0.89	0.95	0.88	0.92	-0.8	0.9	0.9	0.77	0.73	0.89	1.0	0.97	0.56	1.0	0.7	0.95	1.0	0.69	0.96	0.86	0.18		-0.26	0.25	-0.69
Net Tangible Assets	-0.13	-0.15	-0.08	0.19	-0.17	0.07	-0.26	-0.02	0.09	0.2	0.02	-0.21	-0.08	0.15	-0.23	-0.19	-0.11	-0.24	0.18	-0.16	-0.05	-0.19	-0.26		-0.01	0.06
Current Deferred Revenue	0.27	0.14	0.34	0.25	0.22	-0.3	0.26	0.33	0.4	0.27	0.3	0.28	0.32	0.4	0.26	0.45	0.43	0.26	0.41	0.21	0.35	0.29	0.25	-0.01		-0.34
Retained Earnings Total Equity	-0.69	-0.49	-0.69	-0.61	-0.62	0.97	-0.68	-0.77	-0.89	-0.93	-0.88	-0.71	-0.75	-0.83	-0.7	-0.62	-0.77	-0.7	-0.91	-0.61	-0.91	-0.52	-0.69	0.06	-0.34

Click cells to compare fundamentals

Harrow Health Account Relationship Matchups

Harrow Health fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	59.1M	57.5M	98.3M	157.0M	311.8M	327.3M
Other Current Liab	2.4M	2.3M	4.3M	(836K)	27.0M	28.4M
Total Current Liabilities	12.3M	10.8M	9.7M	18.6M	49.3M	51.8M
Total Stockholder Equity	27.7M	27.2M	11.3M	27.2M	70.4M	73.9M
Net Debt	16.2M	19.4M	35.8M	7.9M	116.4M	122.2M
Retained Earnings	(74.0M)	(77.4M)	(95.4M)	(109.5M)	(133.9M)	(127.2M)
Cash	4.7M	4.1M	42.2M	96.3M	74.1M	77.8M
Cash And Short Term Investments	29.9M	32.6M	50.7M	96.3M	82.8M	86.9M
Common Stock Shares Outstanding	26.5M	25.9M	26.8M	27.5M	32.6M	34.2M
Liabilities And Stockholders Equity	59.1M	57.5M	98.3M	157.0M	311.8M	327.3M
Other Stockholder Equity	101.7M	104.6M	106.7M	136.7M	204.6M	214.9M
Total Liab	31.7M	30.6M	87.4M	130.1M	241.8M	253.8M
Total Current Assets	36.8M	40.1M	60.7M	118.3M	139.1M	146.0M
Short Long Term Debt Total	21.0M	23.5M	78.0M	104.2M	190.5M	200.0M
Other Current Assets	786K	951K	1.3M	22.0M	9.0M	9.4M
Accounts Payable	7.4M	3.9M	5.2M	18.6M	21.4M	22.5M
Non Current Liabilities Total	19.4M	19.8M	77.7M	111.5M	192.4M	202.0M
Property Plant And Equipment Net	11.9M	11.3M	9.1M	11.0M	12.4M	13.1M
Non Current Assets Total	22.3M	17.3M	37.7M	37.2M	172.7M	181.3M
Property Plant And Equipment Gross	11.9M	11.3M	16.9M	20.1M	20.4M	21.4M
Long Term Debt	12.2M	12.4M	71.7M	104.2M	183.2M	192.3M
Net Tangible Assets	25.0M	24.9M	(6.2M)	1.4M	1.6M	1.6M
Current Deferred Revenue	57K	66K	16K	113K	75K	71.3K
Retained Earnings Total Equity	(74.0M)	(77.4M)	(95.4M)	(109.5M)	(98.5M)	(103.5M)
Capital Surpluse	101.7M	104.6M	106.7M	137.1M	157.6M	85.0M
Short Term Debt	2.4M	4.5M	280K	723K	806K	765.7K
Non Currrent Assets Other	7.7M	3.8M	12.4M	2.0M	(2.1M)	(2.0M)
Accumulated Other Comprehensive Income	(2.8M)	(4.4M)	0.0	(409K)	(368.1K)	(386.5K)
Property Plant Equipment	5.4M	4.5M	3.1M	3.5M	4.0M	3.9M
Short Term Investments	25.2M	28.5M	8.5M	5.6M	8.7M	9.9M
Net Receivables	2.7M	2.7M	4.5M	6.4M	36.5M	38.3M
Long Term Debt Total	12.2M	12.4M	71.7M	104.2M	119.8M	125.8M
Capital Lease Obligations	7M	7.3M	6.3M	8.1M	7.3M	4.3M
Inventory	3.3M	4.0M	4.2M	6.5M	10.9M	11.4M
Non Current Liabilities Other	7.2M	7.5M	6.0M	7.3M	8.4M	8.9M
Intangible Assets	2.3M	1.9M	17.1M	25.8M	162.0M	170.1M

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Harrow Health in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Harrow Health's short interest history, or implied volatility extrapolated from Harrow Health options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Harrow Health is a strong investment it is important to analyze Harrow Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Harrow Health's future performance. For an informed investment choice regarding Harrow Stock, refer to the following important reports:

How To Invest In Harrow

Details

Is Harrow Stock a good investment?

Details

What is Harrow Health's Net Worth?

Details

Largest Pharmaceuticals Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Harrow Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons.

For more information on how to buy Harrow Stock please use our How to Invest in Harrow Health guide.

You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Harrow Stock analysis

When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.

	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm

Is Harrow Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.64)

Earnings Share

(0.75)

Revenue Per Share

3.992

Quarterly Revenue Growth

0.788

Return On Assets

0.0022

The market value of Harrow Health is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Harrow Current Deferred Revenue vs Non Current Assets Total Analysis

Current Deferred Revenue vs Non Current Assets Total

Current Deferred Revenue vs Non Current Assets Total Correlation Analysis

Correlation Coefficient

Current Deferred Revenue

Non Current Assets Total

Harrow Health fundamental ratios Correlations

Harrow Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Harrow Health fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Harrow Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Short Long Term Debt Total	+ 1.0	Total Liab
Non Current Liabilities Total	+ 1.0	Total Liab
Long Term Debt	+ 1.0	Total Liab
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Long Term Debt	+ 1.0	Short Long Term Debt Total

Other Stockholder Equity	- 0.96	Retained Earnings
Common Stock Shares Outstanding	- 0.94	Retained Earnings
Retained Earnings Total Equity	- 0.93	Common Stock Shares Outstanding
Property Plant And Equipment Gross	- 0.92	Retained Earnings
Common Stock Total Equity	- 0.92	Retained Earnings
Retained Earnings Total Equity	- 0.91	Property Plant And Equipment Gross